Finding The Way To Confidence, Accountability

There is clearly a problem with the process by which universities recover their indirect costs of research. Congressional hearings, media reports, and discussion by university scientists and administrators all reflect a widespread loss of confidence in the present process, and that loss of confidence is in itself a significant problem. Universities must regain public confidence that the expenditure of public funds is handled in a fair and prudent fashion. The fact that there are problems in th

Written byMarvin Ebel
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

The fact that there are problems in the indirect costs system does not come as a complete surprise to university presidents, administrators, and principal investigators. In 1987 the Association of American Universities appointed an Ad Hoc Committee on Indirect Costs, chaired by Cornelius Pings, provost of the University of Southern California in Los Angeles. The Pings Committee was charged with studying indirect costs and recommending ways to simplify the system and to reduce variations in the rate. It is hard to argue with the overall success of the partnership in basic research between the federal government and the research universities. Federal sponsorship of research has grown from insignificant levels in the period immediately following World War II to the present situation, in which most U.S. basic research is conducted at colleges and universities. The access to the enthusiasm and fresh ideas of graduate and even undergraduate students permits a research ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies